Key Insights

Highlights

Treatment Research

2 treatments under study, led by Dlbs1033

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02133521Phase 2Terminated

DLBS1033 for Acute Ischemic Stroke Patients

Showing all 1 trials

Research Network

Common Treatments

  • Dlbs10331
  • Placebo1

Active Sponsors

  • Dexa Medica Group1

Related Conditions

  • Acute Ischemic Stroke1
  • Partial Anterior Circulation Infarct1

Activity Timeline